Company: ATRA
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059322
Chunk: 67

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 67
---
4, the Company’s non-employee directors had the following RSUs outstanding: Mr. Dobmeier, no RSUs outstanding; Mr. Fust, 6,000 RSUs; Dr. Gallagher, 6,000 RSUs; Mr. Heiden, 6,000 RSUs; Mr. Mallik, 6,000 RSUs; Dr. Roncarolo, 6,000; and Mr. Ciongoli, no RSUs outstanding. (2) Mr. Dobmeier’s term on the Board expired in June 2024. (3) Mr. Ciongoli waived his right to receive non-employee director compensation. Our non-employee director compensation policy, pursuant to which we compensate our non-employee directors with a combination of cash and equity, is intended to be fair and competitive to account for the time and effort required of a director of the Company. The annual cash compensation contained in this policy, set forth below, is payable in equal quarterly installments, in arrears following the end of each quarter in which the service occurred, pro-rated for any partial months of service. The Human Capital Committee reviews pay levels for non-employee directors regularly with assistance from its compensation consultant, who prepares a comprehensive assessment of our non-employee director compensation program. That assessment includes benchmarking of director compensation against the same peer group used for executive compensation purposes and an update on recent trends in director compensation. Following that review, the Human Capital Committee approved changes to the equity compensation in the non-employee director compensation policy for 2023. Our director compensation is set forth below: • Annual Board Service Retainer: All Directors other than Lead Director or Chair of the Board: $45,000 Lead Director: $75,000 Chair of the Board: $85,000 • Annual Committee Service Retainer (Chair): Chair of the Audit Committee: $20,000 Chair of the Human Capital Committee: $15,000 Chair of the Nominating and Corporate Governance Committee: $10,000 • Annual Committee Service Retainer (Non-Chair): Audit Committee: $10,000 Human Capital Committee: $7,500 Nominating and Corporate Governance Committee: $5,000 Research and Development Committee: $5,000 We have reimbursed, and under this policy will continue to reimburse, our non-employee directors for their travel, lodging and other reasonable expenses incurred in attending meetings of our Board and committees of our Board.

<div align='center'>43</div>

The non